US FDA advisers mull approval of Moderna’s COVID booster jab
Al Jazeera
With 66 million American adults still unvaccinated, President Biden is pushing for emergency approvals of booster jabs.
A US Food and Drug Administration (FDA) advisory panel is expected to vote on whether to approve a third dose of Moderna Inc’s COVID-19 vaccine, as the Biden administration ramps up efforts to get more Americans vaccinated.
Moderna is hoping for approval on Thursday of a booster jab that includes 50 micrograms of vaccine, half the strength of its regular dose but still higher than the Pfizer-BioNTech shot, which contains 30 micrograms.
The FDA last month approved Pfizer-BioNTech booster jabs for specific segments of the US population.
More Related News